Aurobindo Pharma has informed the officials of the Company will be participating in the investor meetings on June 13, 2023 as part of Investec Asia CXO Conference Singapore 2023. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This intimation is submitted pursuant to Regulation 30(6) of the Listing Regulations. The schedule of the meeting is attached.
The above information is a part of company’s filings submitted to BSE.